Nitric oxide pathways in Alzheimer's disease and other neurodegenerative dementias

Neurological Research

Volumn 26, Issue 5, 2004, Pages 563-566

  Togo, Takashi ^a   Katsuse, Omi ^a   Iseki, Eizo ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Dementia with Lewy bodies; Microvasculopathy; Neuroinflammation; Nitric oxide; Nitric oxide synthase

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; DEGENERATIVE DISEASE; DEMENTIA; ENDOTHELIUM CELL; GLIA; HUMAN; INFLAMMATION; LEWY BODY; NERVE CELL; NEUROLOGIC DISEASE; PATHOGENESIS; PROTEIN EXPRESSION; RISK FACTOR;

ALZHEIMER DISEASE; CEREBRAL ARTERIES; CEREBROVASCULAR DISORDERS; DEMENTIA; ENCEPHALITIS; HUMANS; NERVE DEGENERATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 3042727914     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164104225016236     Document Type: Article

References (46)

1. Paulson OB. Blood-brain barrier, brain metabolism and cerebral blood flow. Eur Neuropsychopharmacol 2002; 12: 495-501
2. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21: 383-421
3. McGeer PL, McGeer EG. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 1995; 21: 195-218
4. Togo T, Akiyama H, Iseki E, et al. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J Neuroimmunol 2002; 124: 83-92
5. Iseki E, Marui W, Akiyama H, et al. Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using alpha-synuclein-immunohistochemistry. Neurosci Lett 2000; 286: 69-73
6. Togo T, Iseki E, Marui W, et al. Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies. J Neurol Sci 2001; 184: 71-75
7. Brown GC, Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 2003; 27: 325-355
8. Bredt DS. Endogenous nitric oxide synthesis: Biological functions and pathophysiology. Free Radic Res 1999; 31: 577-596
9. Law A, Gauthier S, Quirion R. Say NO to Alzheimer's disease: The putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Brain Res Rev 2001; 35: 73-96
10. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376
11. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265-9269
12. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526
13. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate. Biochemistry 1988; 27: 8706-8711
14. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682-685
15. Marsden PA, Schappert KT, Chen HS, et al. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 1992; 307: 287-293
16. Xie QW, Cho HJ, Calaycay J, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225-228
17. Pollock JS, Forstermann U, Mitchell JA, et al. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991; 88: 10480-10484
18. Stuehr DJ, Cho HJ, Kwon NS, et al. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 1991; 88: 7773-7777
19. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-13728
20. Schmidt HH, Pollock JS, Nakane M, et al. Ca2+/calmodulin-regulated nitric oxide synthases. Cell Calcium 1992; 13: 427-434
21. Lee TJ. Nitric oxide and the cerebral vascular function. J Biomed Sci 2000; 7: 16-26
22. Kubes P, Kanwar S, Niu XF, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 1993; 7: 1293-1299
23. Niu XF, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 1994; 74: 1133-1140
24. Hatake K, Kakishita E, Wakabayashi I, et al. Effect of aging on endothelium-dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin. Stroke 1990; 21: 1039-1043
25. Higashi Y, Oshima T, Ozono R, et al. Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans. Hypertension 1997; 30: 252-258
26. Malek AM, Izumo S, Alper SL. Modulation by pathophysiological stimuli of the shear stress-induced up-regulation of endothelial nitric oxide synthase expression in endothelial cells. Neurosurgery 1999; 45: 334-345
27. Buee L, Hof PR, Bouras C, et al. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol 1994; 87: 469-480
28. de la Torre JC, Mussivand T. Can disturbed brain microcirculation cause Alzheimer's disease? Neurol Res 1993; 15: 146-153
29. Mancardi GL, Perdelli F, Rivano C, et al. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease. Acta Neuropathol 1980; 49: 79-83
30. de la Torre JC, Stefano GB. Evidence that Alzheimer's disease is a microvascular disorder: The role of constitutive nitric oxide. Brain Res Brain Res Rev 2000; 34: 119-136
31. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001; 107: 135-142
32. Peng HB, Libby P, Liao JK. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 1995; 270: 14214-14219
33. de la Torre JC. Alzheimer's disease: How does it start? J Alzheimers Dis 2002; 4: 497-512
34. Kalaria RN. Comparison between Alzheimer's disease and vascular dementia: Implications for treatment. Neurol Res 2003; 25: 661-664
35. Stewart VC, Heales SJ. Nitric oxide-induced mitochondrial dysfunction: Implications for neurodegeneration. Free Radic Biol Med 2003; 34: 287-303
36. Akama KT, Albanese C, Pestell RG, et al. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc Natl Acad Sci USA 1998; 95: 5795-5800
37. Goodwin JL, Kehrli ME Jr, Uemura E. Integrin Mac-1 and beta-amyloid in microglial release of nitric oxide. Brain Res 1997; 768: 279-286
38. Wallace MN, Geddes JG, Farquhar DA, et al. Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques. Exp Neurol 1997; 144: 266-272
39. Dickson DW, Lee SC, Mattiace LA, et al. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993; 7: 75-83
40. Combs CK, Karlo JC, Kao SC, et al. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 2001; 21: 1179-1188
41. Hu J, Akama KT, Krafft GA, et al. Amyloid-beta peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release. Brain Res 1998; 785: 195-206
42. Rossi F, Bianchini E. Synergistic induction of nitric oxide by beta-amyloid and cytokines in astrocytes. Biochem Biophys Res Commun 1996; 225: 474-478
43. Lee SC, Zhao ML, Hirano A, et al. Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: Association with Hirano bodies, neurofibrillary tangles, and senile plaques. J Neuropathol Exp Neurol 1999; 58: 1163-1169
44. Vodovotz Y, Lucia MS, Flanders KC, et al. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J Exp Med 1996; 184: 1425-1433
45. Yamada T, McGeer PL, McGeer EG. Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins. Acta Neuropathol 1992; 84: 100-104
46. Katsuse O, Iseki E, Kosaka K. Immunohistochemical study of the expression of cytokines and nitric oxide synthases in brains of patients with dementia with Lewy bodies. Neuropathology 2003; 23: 9-15